Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-FR
Language French French
Date Updated 2020-07-24 2020-07-24
Drug Identification Number 02244756 02244756
Brand name BIAXIN XL BIAXIN XL
Common or Proper name Biaxin Biaxin
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients CLARITHROMYCIN CLARITHROMYCIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60s 60s
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-12-08 2016-12-08
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments currently on long term out of stock currently on long term out of stock
Health Canada comments